Intermittent preventive treatment and its effect on maternal and neonatal malaria in two health facilities, Rivers State, south-south Nigeria
http://dx.doi.org/10.4314/njpar.v40i2.4
Keywords:
pregnancy, preventive treatment, Malaria parasitaemiaAbstract
The use of sulphadoxine pyrimethamine (IPTp-Sp) as a control measure for malaria infection has been found to prevent malaria in pregnancy. However there are still gaps in levels of compliance. This study was carried out to evaluate these gaps in compliance to IPTp-Sp and its effects on placental and neonatal malaria in two health facilities in Rivers State, Nigeria. Three hundred consented participants were administered questionnaires, and blood samples collected from maternal peripheral blood (MPB), placental blood (PLB) and neonatal cord blood (NCB) immediately after delivery. Malaria parasitaemia and anaemiawere analysed using standard parasitological and haematological methods of examination. Results showed that83(27.7%) MPB, 66(22.0%) PLB, and 40(13.3%) NCB were positive to malaria parasitaemia cases. On IPTp-SP usage, 261(87.0%) received SP in different doses while 39(13.0%) did not (p<0.05). Sixty-six (25.3%) of users and 17(43.6%) of non-users tested positive to malaria parasitaemia (p<0.05). Sixty-six infected mothers who received IPTp-SP, 49(74.2%), 15(22.7%) and 2(3.0%) had 1, 2, 3 doses respectively. Maternal anaemia was 12(4.6%) for IPTp-SP users and 12(30.8%) for nonusers while neonatal recorded 4(1.5%) and 5(13.5%) respectively (p<0.05). The birth-weight of the babies weighing <2.5 kg recorded 3(1.2%) for IPTp-SP users and 6(16.2%) for non-users. Knowledge on SP showed that 239(79.7%) had good knowledge while 61(20.3%) had no knowledge and 13(4.3%), 201(67.0%) and 86(28.7%) commenced treatment on first, second and third trimesters respectively. Prevalence based on age showed that 22(15.1%) mothers within the age of 31-40 years, while prevalence based on education showed that mothers who had tertiary education has the least infection 21(18.3%). The use and compliance to IPTp-Sp is observed to reduce the prevalence and complications of malaria among the studied population. However, there are still gaps in compliance and efforts should be intensified towards total compliance which includes enforcing total compliance, availability of drugs and education of the pregnant women.
References
Akinleye, S. O., Falade, C.O.and Ajayi I. O. 2009. Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centres in rural south-west Nigeria: A cross-sectional study. Biomedical central pregnancy and childbirth, 9(28): 1471-2393.
Amon E., Godfrey M., Selemani M., Ahmed M., Iddajovana P.K. and Hadija K. 2014. Factors affecting uptake of optimal doses of sulphadoxinepyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania. Malaria Journal, 13(22): 1-9.
World Health Organization 2003. Lives at risk: malaria in pregnancy. Available from: http://www.rbm.who. int. Accessed 2, October, 2017
Malhotra, J. 2013. Gravidity and malaria. http://www.slideshare.net/NarendraMalhotra/malariaaicog-2013
Federal Ministry of Health (FMoH), Nigeria. National Guidelines and Strategies for Malaria Prevention and Control during Pregnancy. Sunmap 2010.
World Health Organization. 2007. Malaria in pregnancy: Guidelines for measuring key monitoring and evaluation indicators. 2007. http://www.who.int/ malaria. Accessed 2/10/2017
Okpere, E. E., Enabudoso, E. J. and Osemwenkha, A. P. 2010. Malaria in pregnancy. Nigerian Medical Journal, 51: 109-13.
Schantz-Dunn J. and Nour M. N. 2009. Malaria and pregnancy: A global health perspective. Reviews in Obstetrics &Gynecology, 2(3): 186-192.
World Health Organization. 2011. Roll Back Malaria Factsheet No. 94. Geneva. Available from: http://www.who.int/mediacentre/factsheets/fs094en
Ukaga, C. N., Nwoke, B. E. B., Udujih, O. S., Udujih, O. G., Ohaeri, A. A., Anosike, J. C., Udujih, B. U. and Nwachukwu, M. I. 2007. Placental malaria in Owerri, Imo State, south-eastern Nigeria. Tanzania Health Research Bulletin, 9(3): 180-185.
Nduka, F. O., Nwosu, E. and Oguariri, R. M. 2011. Evaluation of the effectiveness and compliance of intermittent preventive treatment (IPT) in the control of malaria in pregnant women in south eastern Nigeria. Annals of Tropical Medicine and Parasitology, 105(8): 599-605.
Gutman J., Mwandama D., Wiegand R. E., Ali D., Mathanga D. P. and Skarbinski J. 2013. Effectiveness of intermittent preventive treatment with sulfadoxinepyrimethamine during pregnancy on maternal and birth outcomes in Machinga District, Malawi. Journal of Infectious Diseases, 208(6): 907-16.
Matteelli, A., Caligaris, S., Castelli, F. and Carosi, G. 1997. The placenta and malaria. Annals of Tropical Medicine and Parasitology, 91: 803-10.
Luciana, V. M., Carlos, E. T., Iva’n G.C., David N. O., Carlos, P.G. 2013. Intravital placenta imaging reveals microcirculatory dynamics impact on sequestration and phagocytosis of Plasmodium-infected erythrocytes. PLOS 9(1): e1003154.
Peters, P.J., Thigpen, M. C., Parise, M. E. and Newman, R. D. 2007. Safety and toxicity of Sulfadoxinepyrimethamine: Implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Safety, 30(6): 481-501.
World Health Organization. 2016. Intermittent preventive treatment in pregnancy (IPTp). Retrieved March 17, 2016.
MenÑndez, C., BardajÖ, A., Sigauque, B., Sanz, S., Aponte, J. J., Mabunda, S. and Alonso, P.L. 2010. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. Public Library of Science PLoS ONE, 5(2): e9438.
Charles, I. T. W. and Eme. O A. 2013. Utilization of intermittent preventive treatment of malaria by pregnant women in Rivers State, Nigeria. International Journal of Preventive Medicine, 4(1): 63-71.
Josephine, N. C., Emmanuel, T. I., Adeniyi, K. A., Oluwagbemiga, O.A., Philip, U. A., Adetoro, O.O. 2016. Knowledge, attitude and practice on malaria prevention and sulfadoxine-pyrimethamine utilisation among pregnant women in Badagry, Lagos State, Nigeria. Malaria World Journal, 7(3): 1-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Nigerian Journal of Parasitology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
